791 related articles for article (PubMed ID: 15691286)
1. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
[TBL] [Abstract][Full Text] [Related]
2. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
3. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
[TBL] [Abstract][Full Text] [Related]
4. False recognition helps to distinguish patients with Alzheimer's disease and amnestic MCI from patients with other kinds of dementia.
Hildebrandt H; Haldenwanger A; Eling P
Dement Geriatr Cogn Disord; 2009; 28(2):159-67. PubMed ID: 19696484
[TBL] [Abstract][Full Text] [Related]
5. CERAD test performance and cognitive impairment in Parkinson's disease.
Karrasch M; Laatu S; Martikainen K; Marttila R
Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
[TBL] [Abstract][Full Text] [Related]
6. [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].
Barth S; Schönknecht P; Pantel J; Schröder J
Fortschr Neurol Psychiatr; 2005 Oct; 73(10):568-76. PubMed ID: 16217697
[TBL] [Abstract][Full Text] [Related]
7. Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.
Dierckx E; Engelborghs S; De Raedt R; De Deyn PP; Ponjaert-Kristoffersen I
Psychol Med; 2007 May; 37(5):747-55. PubMed ID: 17164030
[TBL] [Abstract][Full Text] [Related]
8. A total score for the CERAD neuropsychological battery.
Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
[TBL] [Abstract][Full Text] [Related]
9. CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study.
Paajanen T; Hänninen T; Tunnard C; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H; Addneuromed Consortium
J Alzheimers Dis; 2010; 22(4):1089-97. PubMed ID: 20930314
[TBL] [Abstract][Full Text] [Related]
10. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
[TBL] [Abstract][Full Text] [Related]
11. Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction.
Saka E; Elibol B
Parkinsonism Relat Disord; 2009 Nov; 15(9):688-91. PubMed ID: 19446489
[TBL] [Abstract][Full Text] [Related]
12. Facial emotion recognition deficit in amnestic mild cognitive impairment and Alzheimer disease.
Spoletini I; Marra C; Di Iulio F; Gianni W; Sancesario G; Giubilei F; Trequattrini A; Bria P; Caltagirone C; Spalletta G
Am J Geriatr Psychiatry; 2008 May; 16(5):389-98. PubMed ID: 18403572
[TBL] [Abstract][Full Text] [Related]
13. The impact of the CERAD-NP on diagnosis of cognitive deficiencies in late onset depression and Alzheimer's disease.
Künig G; Jäger M; Stief V; Kaldune A; Urbaniok F; Endrass J
Int J Geriatr Psychiatry; 2006 Oct; 21(10):911-6. PubMed ID: 16927401
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
15. Preclinical dementia: an Italian multicentre study on amnestic mild cognitive impairment.
Perri R; Serra L; Carlesimo GA; Caltagirone C;
Dement Geriatr Cogn Disord; 2007; 23(5):289-300. PubMed ID: 17356272
[TBL] [Abstract][Full Text] [Related]
16. Nonepisodic memory deficits in amnestic MCI.
Economou A; Papageorgiou SG; Karageorgiou C; Vassilopoulos D
Cogn Behav Neurol; 2007 Jun; 20(2):99-106. PubMed ID: 17558253
[TBL] [Abstract][Full Text] [Related]
17. The memory alteration test (M@T) discriminates between subjective memory complaints, mild cognitive impairment and Alzheimer's disease.
Rami L; Bosch B; Sanchez-Valle R; Molinuevo JL
Arch Gerontol Geriatr; 2010; 50(2):171-4. PubMed ID: 19375179
[TBL] [Abstract][Full Text] [Related]
18. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F
Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
[TBL] [Abstract][Full Text] [Related]
20. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit.
Maioli F; Coveri M; Pagni P; Chiandetti C; Marchetti C; Ciarrocchi R; Ruggero C; Nativio V; Onesti A; D'Anastasio C; Pedone V
Arch Gerontol Geriatr; 2007; 44 Suppl 1():233-41. PubMed ID: 17317458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]